🇺🇸 FDA
Patent

US 10751281

Auris formulations for treating otic diseases and conditions

granted A61KA61K2039/505A61K31/05

Quick answer

US patent 10751281 (Auris formulations for treating otic diseases and conditions) held by The Regents of the University of California expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K31/05, A61K31/13, A61K31/137